Cogent Biosciences, Inc. (COGT)

Cogent Biosciences Statistics

Total Valuation

COGT has a market cap or net worth of $1.72 billion. The enterprise value is $1.49 billion.

Market Cap	1.72B
Enterprise Value	1.49B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

COGT has 139.49 million shares outstanding. The number of shares has increased by 113.09% in one year.

Current Share Class	139.41M
Shares Outstanding	139.49M
Shares Change (YoY)	+113.09%
Shares Change (QoQ)	+1.73%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	69.94%
Float	94.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	12.64
P/TBV Ratio	15.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.13, with a Debt / Equity ratio of 0.08.

Current Ratio	5.13
Quick Ratio	4.98
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -84.04% and return on invested capital (ROIC) is -53.27%.

Return on Equity (ROE)	-84.04%
Return on Assets (ROA)	-47.45%
Return on Invested Capital (ROIC)	-53.27%
Return on Capital Employed (ROCE)	-123.02%
Revenue Per Employee	n/a
Profits Per Employee	-$1.31M
Employee Count	205
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.86% in the last 52 weeks. The beta is 0.31, so COGT's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+42.86%
50-Day Moving Average	7.27
200-Day Moving Average	7.99
Relative Strength Index (RSI)	86.76
Average Volume (20 Days)	5,015,777

Short Selling Information

The latest short interest is 12.40 million, so 8.89% of the outstanding shares have been sold short.

Short Interest	12.40M
Short Previous Month	16.52M
Short % of Shares Out	8.89%
Short % of Float	13.15%
Short Ratio (days to cover)	9.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-288.47M
Pretax Income	-227.05M
Net Income	-269.50M
EBITDA	-285.98M
EBIT	-288.47M
Earnings Per Share (EPS)	-$2.04

Balance Sheet

The company has $245.66 million in cash and $17.09 million in debt, giving a net cash position of $228.57 million or $1.64 per share.

Cash & Cash Equivalents	245.66M
Total Debt	17.09M
Net Cash	228.57M
Net Cash Per Share	$1.64
Equity (Book Value)	219.00M
Book Value Per Share	0.97
Working Capital	203.57M

Cash Flow

In the last 12 months, operating cash flow was -$221.77 million and capital expenditures -$1.05 million, giving a free cash flow of -$222.82 million.

Operating Cash Flow	-221.77M
Capital Expenditures	-1.05M
Free Cash Flow	-222.82M
FCF Per Share	-$1.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

COGT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-113.09%
Shareholder Yield	-113.09%
Earnings Yield	-15.71%
FCF Yield	-12.99%

Analyst Forecast

The average price target for COGT is $20.25, which is 64.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.25
Price Target Difference	64.63%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 9, 2020. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Nov 9, 2020
Split Type	Reverse
Split Ratio	0.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1